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Drug overview: Etizolam is a benzodiazepine analogue, 
a thienodiazepene.1 It has gathered some popularity on 
the new psychoactive substance (NPS) market in the UK 
and Europe.
Chemical name(s): 4-(2-chlorophenyl)-2-ethyl-9-
methyl-6H-thieno[3,2- f][1,2,4]triazolo[4,3-a][1,4]
diazepine.2
Brand Names: Etilaam, Etizest, Etizola, Sedekopan, 
Depas, Pasaden.3
Classification: Depressant.
Background: Etizolam is unlicensed in the UK although 
used as a prescribed medication in other countries such 
as India, Italy and Japan.4,5,6 A 1mg tablet is equivalent to 
a 10mg diazepam (Valium) tablet.7
Appearance:  Etizolam typically comes in 1mg and 2mg 
tablets which are often described by online vendors as 
‘pellets’. Its appearance can vary depending on the source 
of purchase: tablets can be blue, pink or white and more 
increasingly may be sold as ‘street Valium’ and therefore 
can appear as light blue tablets with commonly-seen 
Valium markings. When sold as etizolam, it can be found 
in a foil strip packet with the brand name on the foil 
such as Etilaam or Etizest. There are other 
tablets in circulation which are lighter blue 
(similar to blue diazepam colour) and can 
display the markings EZ. Tablets from other 
vendors may simply come as unmarked 
blue, pink or white pills that come loose in 
a zip-seal plastic bag.8
It is also possible to purchase in powder 
form, which is often white.10 Anecdotal 
reports suggest that it is rare for users to 
purchase the powder form in the UK.
Image: Wikimedia commons
Image: Police Scotland 9
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Cost: Etizolam varies in cost, depending on the form and quantity purchased. They 
can range from £1 for single tablets (or in quantities less than 10), to as low as 5p per 
tablet at larger quantities. 100 tablets typically cost around £40. The powder form 
ranges from approximately £10 for 50mg, to £950 for 20 grams.11
Route of administration: Etizolam is generally consumed orally, by swallowing 
tablets or powder placed into gel capsules.8 It can also be taken sublingually (under 
the tongue).10 There are reports of snorting and rectal administration although this 
appears to be rare on the UK scene.
Legal Status: Etizolam was classified as a Class C drug in the May 2017 amendment 
to The Misuse of Drugs Act 1971.23 
Dosage (when prescribed):12
Anxiety disorder 0.25-0.5mg twice daily
Panic disorder 0.5mg twice daily
Insomnia 1-2mg daily
Maximum daily dosage 3mg
Current guidance for prescribing benzodiazepines is that they should not be 
prescribed beyond two weeks to prevent dependence.27 A gradual taper strategy 
when stopping etizolam is also recommended to ease any withdrawal effects. There 
is limited data on etizolam toxicity in the literature.
Recreational oral dose:8
Light Common Strong Heavy
0.5mg 1-2mg 3-4mg 5mg+
Onset, duration and after effects: Oral doses have an onset of 30-60 minutes and 
peak at 3-4 hours. The duration is generally 6-8 hours although higher doses can last 
longer. Usual after effects are between 1-5 hours although many users report little 
after effects, especially if they have had a 7-8 hour period of uninterrupted sleep 
after use.13
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In therapeutic doses, the plasma elimination half-life is between 3.4 and 6 hours 
(normal daily dosage is up to 2mg/day in divided doses, as per the manufacturer).1,12 
However, etizolam has an active main 
metabolite, alpha-hydroxyetizolam, with 
an elimination half-life of about 8.2 hours.1
Typical effects and side effects:8 These 
are some of the typical effects and side 
effects experienced by people who use 
etizolam. Not everyone will experience all 
of the effects listed and many can be dose-
dependent. Overall, etizolam is reported to 
be “well tolerated with little side effects” 
when prescribed.14
Physical effects
Decrease in energy, decreased heart rate, impaired coordination, sleepiness, 
respiratory depression, blurred vision, yawning, constricted pupils, decreased 
appetite, nausea and vomiting, muscle relaxation, dry mouth, headache,  
involuntary eye closure, rebound insomnia (prolonged use).
Mental effects
Mood enhancement, relaxation, reduced anxiety, lowered inhibitions,  
sedative effects, mental confusion, short term memory loss
Comedown effects: Some users report malaise after use but the majority of people 
who use on an occasional basis suggest there is little comedown or hangover. Using 
on a more frequent basis can lead to rebound anxiety and/or depression, with 
difficulty sleeping, problems falling asleep or waking early.
Brain chemistry and pharmacological effects: Etizolam is a full benzodiazepine 
receptor agonist and so has a broadly similar pharmacological profile to 
benzodiazepine drugs such as diazepam.15 It has the full range of group-specific 
benzodiazepine effects: anxiolytic, sedative, hypnotic, anticonvulsant and muscle 
relaxant, and is approximately 10 times more potent than diazepam.7 It differs from 
drugs such as diazepam as it has selective and high affinity binding to postsynaptic 
GABA-A receptor alpha
2
 subunit, which results in specific anxiolytic effects.16
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Patterns of use: Patterns of use appear to be similar to other benzodiazepines. Some 
users report using etizolam as a comedown aid after using stimulant or psychedelic 
drugs.
Etizolam has been a growing feature in drug related deaths. It is not clear from 
the statistics whether people have intended to take etizolam or have believed it to 
be street Valium. In Scotland in 2016, there were 286 deaths for which NPSs were 
implicated in, or potentially contributed to the cause of death. In 277 cases, the 
only NPSs present were benzodiazepines (usually etizolam, but sometimes other 
unlicensed benzodiazepines such as diclazepam or phenazepam).28
Tolerance, dependence and withdrawal: Benzodiazepines such as etizolam which 
are more rapidly eliminated from the body are less likely to accumulate,17 and there 
is evidence to suggest that etizolam 
is less likely to induce tolerance and 
dependence compared with classical 
benzodiazepines.18
However, dependence may develop 
with regular use of benzodiazepines, 
even in therapeutic doses for 
short periods. If benzodiazepines 
are discontinued abruptly after 
regular use, withdrawal symptoms 
may develop. Administration of 
regular doses of benzodiazepines 
can result in physical dependence, 
characterized by a withdrawal syndrome when the drug is discontinued. With larger 
doses, the physical dependence develops more rapidly.19
Withdrawal symptoms include: anxiety, insomnia, headache, dizziness, tinnitus, 
anorexia, vomiting, nausea, tremor, weakness, perspiration, irritability, hypersensitivity 
to visual and auditory stimuli, palpitations, tachycardia (fast heart rate) and postural 
hypotension (drop in blood pressure on standing). In severe and rare cases of 
withdrawal from high doses, patients may develop affective disorders or motor 
dysfunction: seizures, psychosis, agitation, confusion, and hallucinations.20, 21
There is also evidence that links benzodiazepine use (in conjunction with alcohol) as 
a factor in offending.22
Image: Wikimedia commons
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Long term effects/known harms: Etizolam is entirely metabolised by the liver and so 
is contraindicated in those with liver function issues.25 Loss of hypnotic effects and 
increased tolerance may be experienced with long term use. There is also a risk of 
dependence and addiction with repeated use.
Benzodiazepines commonly cause drowsiness, ataxia (neurological conditions 
which affect balance and coordination), dysarthria (difficulty speaking), nystagmus 
(involuntary eye movement) and blepharospasm (involuntary closure of eyelids). 
Coma, hypotension (low blood pressure), bradycardia (slow heart beat) and 
respiratory depression occasionally occur but are seldom serious if these drugs are 
taken alone. Coma usually lasts only a few hours but may be prolonged in elderly 
patients.
Benzodiazepine respiratory depressant effects are more serious in patients with 
severe chronic obstructive airways disease. Severe effects in overdose also include 
rhabdomyolysis (breakdown of muscle tissue) and hypothermia.
Co-ingestion of alcohol and other central nervous system depressants potentiates 
the effects of benzodiazepines and can increase toxicity.
Harm reduction advice for clients, if determined to use:
• Try a small test amount (e.g. 0.5mg) and wait at least 1 hour before taking 
any more.
• Avoid mixing with alcohol.12
• Etizolam can increase the risk of drowsiness, ataxia (problems with 
movement, balance and speech) and disturbances of consciousness 
if taken with neuroleptics, antidepressants, antihistamines, analgesics, 
antiepileptics or other similar prescribed medications.12
• Control quantities taken in one session.
• Try not to use alone and tell friends what they are taking.
• Place sleeping people in the recovery position. If going to sleep, sleep on 
their side.
• Do not drive or operate machinery.
• Be aware that tolerance and dependency can develop quickly.
• Avoid if they have any history of benzodiazepine addiction.
• Seek help from medical support quickly if they experience any negative 
side effects.
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Overdose & Emergencies: As unconsciousness or overdose is possible try to make 
sure a friend is around who is not using the drug. If a user becomes unconscious 
call an ambulance, then place them in the recovery position to prevent choking (see 
images below). The recovery position is for someone who is unconscious but breathing 
normally. If they are not breathing normally CPR is required, with an emphasis on 
giving supplementary oxygen via rescue breaths.
For further information on Overdose & Emergencies see UK and Ireland DrugWatch 
Information Sheet.26
Where to get help: We would advise anyone experiencing issues from  
etizolam or other substances to seek medical support via their GP or NHS 24  
on 08454 24 24 24 (Scotland) or NHS Direct 111 (England and Wales).
There are a wide range of local drug services throughout the UK, to find out 
what is available in your area please use the links below:
    Scotland: Scottish Drug Services    England: Find Support | Frank 
   Wales: Dan 24/7   Northern Ireland: Public Health Agency   ROI: Drugs.IE
For further advice, medical professionals can use the National Poisons Information 
Service 24-hour telephone service on 0344 892 0111 or its online database, TOXBASE. 
Any health professional encountering an unusual or unexpected adverse reaction to 
the use of etizolam (or any other drug) should report the reaction to RIDR. 
Start by placing  
their arm as if they  
are waving.
Place the other arm 
across their chest and 
hold their hand against 
their cheek.
Lift up the knee that 
is furthest from you. 
Continue to hold their 
hand in place.
Turn them on their side  
by pulling the knee 
towards you and down. 
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If you require more information on this briefing or information about NPS training 
please contact staff at SDF on 0141 221 1175 or you can visit the website:
www.sdf.org.uk. 
Disclaimer: This information has been collated from a variety of sources including 
expert users from UK and Europe, information obtained from users through interviews, 
surveys and questionnaires and information from users via relevant websites and 
drug forums. This information sheet is to be used as a rough guide only and SDF/
Drugwatch cannot vouch that all information is factual as there is little scientific or 
medical evidence available on the substance and much of the information has been 
obtained from service users’ reports.
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